Impact of Adjuvant Intravesical Bacillus Calmette-Guérin Treatment on Patients with High-Grade T1 Bladder Cancer

Publisher： Karger

E-ISSN： 1423-0399|96|2|136-141

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.96, Iss.2, 2016-0, pp. : 136-141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravesical Bacillus Calmette-Guérin Therapy for T1 Superficial Bladder Cancer

By  

Urologia Internationalis, Vol. 80, Iss. 1, 2008-01 ,pp. : 74-79

Karger

Access to resources Recommend Favorite

Nephrogenic Adenoma of the Bladder after Intravesical Bacillus Calmette-Guérin Treatment

By  

Urologia Internationalis, Vol. 64, Iss. 4, 2006-01 ,pp. : 229-232

Karger

Access to resources Recommend Favorite

Recurrence and Progression of T1G3 Transitional Cell Carcinoma of the Bladder Treated with Intravesical Bacillus Calmette-Guérin

By  

Urologia Internationalis, Vol. 75, Iss. 2, 2008-07 ,pp. : 107-113

Karger

Access to resources Recommend Favorite

Urinary Fibronectin Levels in Patients Treated with Intravesical Bacillus Calmette-Guérin for Superficial Bladder Cancer

By  

Urologia Internationalis, Vol. 64, Iss. 4, 2006-01 ,pp. : 198-201

Karger

Access to resources Recommend Favorite

Bacillus Calmette-Guérin versus Gemcitabine for Intravesical Therapy in High-Risk Superficial Bladder Cancer: A Randomised Prospective Study

By  

Urologia Internationalis, Vol. 84, Iss. 1, 2010-02 ,pp. : 23-27

Karger

Access to resources Recommend Favorite